Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

 

The Cancer Letter Inc.
PO Box 9905
Washington
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
publication date: Dec 3, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

The American Society of Clinical Oncology is in the final stages of developing a request for proposals for its CancerLinQ system.

The RFP is expected to be issued early in 2014.

ASCO made the announcement last week at a White House Office of Science and Technology Policy event called “Data to Knowledge to Action: Building New Partnerships” at the Ronald Reagan Building in Washington, D.C.

“ASCO is not a business,” the professional society’s president, Clifford Hudis, said to The Cancer Letter. “If our participation in the market ultimately drives the development of a superior tool, but from somebody else, then I would say we have accomplished our goal.

We are an honest broker,” said Hudis, chief of the Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center. “Our goal here is to get this job done and to profit, in terms of society and societal benefit, the maximum number of people. If we support somebody who can do better, that’s fine. We just need this to happen for the good of the patients we serve.”



To access this members-only content, please log in.

If you're not a subscriber why not join today?

If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Letter